Literature DB >> 2830514

Social and economic factors in the choice of lung cancer treatment. A population-based study in two rural states.

E R Greenberg1, C G Chute, T Stukel, J A Baron, D H Freeman, J Yates, R Korson.   

Abstract

We reviewed 1808 hospital charts representing virtually all patients given a diagnosis of non-small-cell lung cancer in New Hampshire and Vermont between 1973 and 1976 and found that the treatment of patients varied according to their marital status, medical insurance coverage, and proximity to a cancer-treatment center. Patients were more likely to be treated with surgery if they were married (odds ratio, 1.67; 95 percent confidence interval, 1.08 to 2.57) or had private medical insurance (1.52; 1.03 to 2.26). Among patients who did not have surgery, those with private insurance were more likely to receive another form of anticancer therapy--either radiation or chemotherapy (1.57; 1.18 to 2.09). Residing farther from a cancer-treatment center was associated with a greater chance of having surgery. Patients 75 years of age and older were less likely to have surgery (0.16; 0.08 to 0.35) or any other tumor-directed therapy (0.32; 0.19 to 0.54). The relation between the type of treatment and a patient's characteristics was not based on apparent differences in tumor stage or functional status, although both these factors were also strongly predictive of the type of treatment. Despite the fact that privately insured and married patients were more aggressively treated, they did not survive longer after diagnosis. We conclude that for non-small-cell lung cancer, socio-economic as well as medical factors determine treatment.

Entities:  

Mesh:

Year:  1988        PMID: 2830514     DOI: 10.1056/NEJM198803103181006

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  58 in total

1.  Coronary artery bypass surgery: are outcomes influenced by demographics or ability to pay?

Authors:  M C Mancini; E M Cush; K Sweatman; J Dansby
Journal:  Ann Surg       Date:  2001-05       Impact factor: 12.969

2.  Associations of income with self-reported ill-health and health resources in a rural community sample of Austria.

Authors:  W Freidl; W J Stronegger; E Rásky; C Neuhold
Journal:  Soz Praventivmed       Date:  2001

Review 3.  The impact of surgery on the multidisciplinary treatment of bronchogenic small cell carcinoma (updated review including ongoing studies).

Authors:  W Theuer; O Selawry; K Karrer
Journal:  Med Oncol Tumor Pharmacother       Date:  1992

4.  High technology drugs for cancer: the decision process for adding to a formulary.

Authors:  J L Glennie; D M Woloschuk; K W Hall
Journal:  Pharmacoeconomics       Date:  1993-12       Impact factor: 4.981

Review 5.  Genome-wide approaches for cancer gene discovery.

Authors:  Paul M Lizardi; Matteo Forloni; Narendra Wajapeyee
Journal:  Trends Biotechnol       Date:  2011-07-13       Impact factor: 19.536

Review 6.  Quality of life measurement for patients undergoing treatment for lung cancer.

Authors:  R J Fergusson; A Cull
Journal:  Thorax       Date:  1991-09       Impact factor: 9.139

7.  Harvard report on cancer prevention. Causes of human cancer. Socioeconomic status.

Authors: 
Journal:  Cancer Causes Control       Date:  1996-11       Impact factor: 2.506

8.  Quality-of-life assessment in cancer clinical trials: an intervention by itself?

Authors:  J Bernhard; H Gusset; C Hürny
Journal:  Support Care Cancer       Date:  1995-01       Impact factor: 3.603

9.  Disparities in the treatment of patients with IL-2 for metastatic renal cell carcinoma.

Authors:  Christopher S Saigal; Christopher M Deibert; Julie Lai; Matthias Schonlau
Journal:  Urol Oncol       Date:  2008-12-12       Impact factor: 3.498

10.  Sex bias in the management of coronary artery disease in Quebec.

Authors:  W D'Hoore; C Sicotte; C Tilquin
Journal:  Am J Public Health       Date:  1994-06       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.